期刊文献+

慢性酒精中毒患者认知功能障碍的评估 被引量:7

The evaluation of cognitive dysfunction in patients with chronic alcoholism
下载PDF
导出
摘要 目的:探讨蒙特利尔认知评估量表(MoCA)和简易智能状态量表(MMSE)联合测评慢性酒精中毒(chronic alcoholism,CA)患者轻度认知功能障碍(MCI)可行性及敏感性。方法:应用MoCA和MMSE分别测评60例CA患者(CA组)和30名健康体检者(对照组)的认知功能。结果:CA组和对照组MMSE和MoCA评分间差异均有统计学意义(P<0.01),2组在视空间、记忆力和反应能力差异均有统计学意义(P<0.01)。结论:MoCA和MMSE联合应用可能有利于早发现CA患者的MCI,MoCA在记忆和局部认知领域缺损敏感性测评优于MMSE,MoCA可为CA患者认知障碍的早期发现和防治提供无创性筛选依据。 Objective:To investigate the feasibility and sensitivity of Montreal cognitive assessment (MoCA) and mini-mental state examination(MMSE) in the evaluation of mild cognitive impairment (MCI) in patients with chronic alcoholism(CA). Methods :The cognitive function of 60 patients with CA( CA group) and 30 healthy people( control group) were evaluated by MoCA and MMSE. Results:The differences of the scores of MoCA and MMSE between CA group and control group were statistically significant (P 〈 0.01 ). The differences of the visual space and memory and reaction abilities in two groups were statistically significant(P 〈 0.01 ). Conclusions :The federated applications of MoCA and MMSE are beneficial to find the MCI patients with CA in the early stage. The memory and sensitivity of the impairment in local cognitive domain evaluated by MoCA are better than MMSE. MoCA can provide an evidence for early finding, preventing and treating the cognitive impairment in patients with CA.
出处 《蚌埠医学院学报》 CAS 2013年第10期1309-1311,共3页 Journal of Bengbu Medical College
关键词 酒精中毒 认知功能障碍 alcoholism cognitive impairment
  • 相关文献

参考文献10

二级参考文献34

  • 1潘志杰,刘微波,周建英.阻塞性睡眠呼吸暂停低通气综合征老年患者的认知功能评价[J].中华结核和呼吸杂志,2005,28(6):411-412. 被引量:25
  • 2Gauthier S,Reisberg B,Zaudig M,et al.Mild cognitive impairment[J].Lancet,2006,367(9518):1262-70.
  • 3Findley L J,Barth J T,Powers D C,et al.Cognitive impairment inpatients with obstructive sleep apnea and associated hypoxemia[J].Chest,1986,90(5):686-90.
  • 4Fuchs B D,McMaster J,Smull G,et al.Underappreciation of sleep disorders as a cause of motor vehicle crashes[J].Am J Emerg Med,2001;19(7):575-8.
  • 5Gosselin N,Mathieu A,Mazza S,et al.Attentional deficits in patients with obstructive sleep apnea syndrome:An event-related potential study[J].Clin Neurophysiology,2006,117(10):2228-35.
  • 6Nasreddine Z S,Phillips N A,Bedirian V.The montreal cognitive assessment,MoCA:A brief screening tool for mild cognitive impairment[J].J Am Geriatr Soc,2005,53(4):695-9.
  • 7Ferini Strambi L,Baietto C,Di Gioia M R.Cognitive dysfunction in patients with obstructive sleep apnea(OSA):partial reversibility after continuous positive airway pressure(CPAP)[J].Drain Bull,2003,61(1):87-92.
  • 8Nobili L,Schiavi G,Bozano E,et al.Morning increase of whole bloodviscosity in obstructive sleep apnea syndrome[J].Clin Hemorheol Microcirc,2000,22:21-7.
  • 9Awad N, Gagnon M, Messier C. The relationship between impaired glu- cose tolerance, type 2 diabetes, and cognitive function [ J ]. J Clin Exp Neuropsychol,2004 ;26 : 1044-80.
  • 10Van Harten B, de Leeuw FE, Weinstein HC, et al. Brain imaging in pa- tients with diabetes: a systematic review [ J ]. Diabetes Care, 2006 ; 29 : 2539-48.

共引文献114

同被引文献33

  • 1乐敏,厉有名.酒精所致多脏器损伤及其相关机制[J].现代医药卫生,2005,21(4):417-420. 被引量:10
  • 2黄燕萍.慢性酒依赖者认知功能的对照研究[J].中国行为医学科学,2005,14(4):332-333. 被引量:20
  • 3GAUTHIER S, REISBERG B, ZAUDIG M, et al. Mild cognitive impairment [ J ]. Lancet,2006,367 ( 9518 ) : 1262.
  • 4AARSLAND D, BRONNICK K, WILLIAMS-GRAY C, et al. Mild cognitive impairment in parkinson disease: a multicenter pooledanalysis[ J]. Neurology,2010,75 (12) : 1062.
  • 5AARSLAND D, MUNIZ G, MATTHEWS F. Nonlinear decline of mini- mental state examination in Parkinson's disease [ J ]. May Disord,2011,26(2) :334.
  • 6NASREDDINE ZS, PHILLIPSh NA, BEDIRIAN V, et al. The montrea| cognitive assessment, MoCA : a brief screening tool for mild cognitive impairment [ J ]. J Am Geriatr Soc, 2005,53 (4) : 695.
  • 7BIUNDO R, WEIS L, FACCHINI S, et al. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia[J]. Parkinsonism Retat Disords,2014,20(4) :394.
  • 8. JELLINGER KA. Mild cognitive impairment in Parkinson disease: heter rogenous mechanisms [ J ]. J Neural Transm, 2013,120 ( 1 ) : 157.
  • 9IRWIN D J, WHITE MT, TOLEDO JB, et al. Neuropathologic substrates of Parkinson disease dementia[ J]. Ann Neurol,2012, 72(4) :587.
  • 10WEINTRAUB D, MAVANDADI S, MAMIKONYAN E, et al. Atomoxetine for depression and other neuropsyehiatrie symptoms in Parkinson disease [ J ]. Neurology, 2010,75 ( 5 ) :448.

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部